IBCG25 Annual Retreat
Houston HoustonWritten by Dr Roberto Contieri The 3rd Annual International Bladder Cancer Group (IBCG) Retreat was held in Houston from August 21–23, 2025. This meeting once again demonstrated the prestige and unique role of the IBCG in shaping the future of bladder cancer research and care. In his President’s Welcome, Dr. Ashish Kamat highlighted the spirit of collaboration, inclusiveness, and patient-centeredness that defines IBCG. Over two days, more than 100 leading clinicians, researchers, regulators, and patient advocates came together to tackle the most pressing challenges in bladder cancer. The Retreat has become a cornerstone for the uro-oncology community. The depth of discussion, the focus on clinically meaningful outcomes, and the collegial atmosphere underscored its pivotal importance for both research and practice. One of the most striking aspects was the truly global nature of the gathering – with participants from over 25 countries across North and South America, Europe, Asia, and beyond. The diversity of expertise and perspectives created a vibrant exchange of ideas and reinforced the IBCG’s mission to build a worldwide network of collaboration.This year’s program centered on two major themesBiomarkers in Urothelial CancerAdvancing the integration of biomarkers into clinical workflows, from early detection to risk stratification, treatment selection, and […]